Every 10-Q that Fluor Corporation (FLR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow FLR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full FLR filings page.
Fluor Corporation reported solid underlying results for the quarter and six months ended June 30, 2026. Revenue was $4,329 million for the quarter and $7,991 million year-to-date, with earnings before taxes of $156 million and $262 million, respectively. Net earnings attributable to Fluor were $114 million for the quarter and $274 million for the six months, while equity-method results shifted from large prior-year gains tied to NuScale revaluations to modest 2026 earnings.
Urban Solutions grew revenue on mining, metals and life sciences work, though profitability was tempered by a $44 million impact from foreign exchange, a subcontractor bankruptcy and client changes on an infrastructure project. Energy Solutions saw lower revenue as projects neared completion but much higher margins from favorable close-out items. Mission Solutions’ year-to-date result was reduced by a $98 million legal charge related to a court ruling on a long-running dispute.
Fluor completed the divestiture of NuScale, with NuScale share sales since September 2025 generating $2.43 billion of cash. Cash and cash equivalents plus marketable securities totaled about $3.0 billion at June 30, 2026, despite negative operating cash flow of $207 million driven largely by $357 million of tax payments linked to the NuScale share conversion. The company repurchased 17 million shares for $816 million in the first half and ended the quarter with backlog of $26,891 million, 85% on reimbursable terms, and remaining unsatisfied performance obligations of $25,861 million.
Fluor Corporation reported results for the three months ended March 31, 2026, with net earnings attributable to Fluor of $160 million compared with a loss of $241 million in 2025. Basic EPS was $1.10 versus a loss of $1.42 per share.
Revenue was $3.66 billion, down from $3.98 billion, as several major projects neared completion, and total segment profit fell to $8 million from $131 million due to a $96 million Mission Solutions legal charge and $37 million of cost growth on a large mining joint venture project.
Results were supported by a $124 million gain on the sale of CFHI and equity method earnings of $51 million, including a $176 million gain on NuScale forward sale contracts that more than offset NuScale fair value losses. Operating cash flow improved to $110 million from a use of $286 million.
Fluor completed or advanced the divestiture of its NuScale stake, generating $1.35 billion of proceeds in February 2026 and an additional $473 million in April 2026, and sold CFHI for $124 million. Cash and cash equivalents reached $3.19 billion, while total backlog was stable at $25.73 billion and remaining unsatisfied performance obligations were $24.53 billion.
During the quarter, the company repurchased about 11.2 million shares for $516 million, and the Board expanded the authorization to 96 million shares, leaving over 28 million shares available. Fluor also recorded a charge reflecting a federal jury’s $15 million False Claims Act damages verdict, related attorneys’ fees and other estimated amounts, and disclosed new NuScale- and Fluor-related securities litigation.
Fluor Corporation reported a challenging quarter as a court-related reversal in Energy Solutions drove a swing to loss. Revenue was $3,368 million and operating loss was $496 million, resulting in a net loss of $697 million (diluted EPS $4.30) for the three months ended September 30, 2025. For the nine months, net earnings reached $1,499 million, largely from a $2.3 billion mark‑to‑market gain on the investment in NuScale.
Segment results were mixed: Urban Solutions grew revenue on life sciences and mining but faced delay and cost adjustments; Energy Solutions was impacted by a $653 million reversal tied to a long‑completed Australian project; Mission Solutions held steady with government work. Backlog was $28,236 million and remaining unsatisfied performance obligations were $26,900 million, supporting future activity.
Liquidity remained solid with cash and equivalents of $2,776 million and total debt of $1,070 million. The company repurchased $365 million of stock year‑to‑date and sold 10 million NuScale shares for $414 million, followed by 5 million more in October for $191 million. An agreement provides for converting 111 million NuScale units to registered shares, with a structured monetization program targeted to complete by the end of April 2026.